Global /United States /Healthcare /Biotechnology /BIOF
chevron_leftBack
Blue Biofuels, Inc. logo

Blue Biofuels, Inc.

BIOF
OTCMKTS: BIOF Delayed
0.1329USD -1.6%
As of 15 June 2026, Blue Biofuels, Inc. has a market cap of $43.56M USD, ranking #31546 globally and #4552 in the United States. It ranks #2858 in the Healthcare sector, and #553 in the Biotechnology industry.
Global Rank
31546
Country Rank
4552
Sector Rank
2858
Industry Rank
553
Key Stats
Market Cap
$43.56MUSD
Enterprise Value
$45.71MUSD
EBITDA (TTM)
-$3.57MUSD
Net Income (TTM)
-$2.87MUSD
PB Ratio
-11.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Benjamin Slager open_in_new
Employees
7
Founded
2012
Website
bluebiofuels.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.6% -9.3% -3.9% -21% -25% 14%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
BIOF
Blue Biofuels Inc
ISIN: US09530Q1022
Shares Out.:
320.948M1 Shares Float: 218.08M2
TV:
SA:
YF:
GF:
BA:
MS:
0.1329 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Blue Biofuels, Inc.

Blue Biofuels, Inc., a technology company, focuses on the renewable energy, biofuels, and lignin technologies. It develops Cellulose-to-Sugar (CTS), a mechanical/chemical dry process for converting cellulose material, including grasses and agricultural waste into sugar and lignin, as well as plant-based feedstock into soluble sugars for use in the biofuels industry. The company also licenses Vertimass Process to convert ethanol into sustainable aviation fuel (SAF) and other renewable biofuels, including bio-gasoline. The company was formerly known as Alliance Bioenergy Plus, Inc. and changed its name to Blue Biofuels, Inc. in August 2021.Blue Biofuels, Inc. was incorporated in 2012 and is based in Palm Beach Gardens, Florida.

Similar Companies

Industry: Biotechnology (United States)
Name
Market Cap diff.
PE
AMGN
$182.42B
419K%
23.9
GILD
$159.92B
367K%
19.0
NTRA
$27.6B
63K%
-
$26.3B
60K%
20.0
$25.03B
57K%
20.4
MRNA
$18.13B
42K%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
ARGX
$47.84B
41.39B EUR
110K%
39.9
$44.84B
68.19T KRW
103K%
35.5
CSL
$42.36B
60.27B AUD
97K%
29.3
LONN
$42.3B
33.71B CHF
97K%
37.2
068270
$28.11B
42.76T KRW
64K%
43.8
BNTX
$25.69B
59K%
-
chevron_leftBack